Seven Eight Capital’s Cantel Medical Corporation CMD Stock Holding History

Seven Eight Capital’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,432	Closed	-$240K	–	684
2020 Q2	$240K	Buy	+5,432	New	+$203K	0.18%	239
2018 Q3	–	Sell	-4,600	Closed	-$452K	–	747
2018 Q2	$452K	Buy	+4,600	New	+$514K	0.03%	372

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Seven Eight Capital's CMD Position: Q3 2020 in Review

Seven Eight Capital sold out of Cantel Medical Corporation (CMD) in Q3 2020, closing a stake of 5,432 shares — an estimated $240K sold.

Seven Eight Capital first reported a position in CMD in Q2 2018 and held it in 2 quarters. The position peaked at $452K in Q2 2018. 196 funds tracked by Wall St. Rank hold CMD as of Q3 2020.

Seven Eight Capital reported no remaining Cantel Medical Corporation position as of Q3 2020 after selling out during the quarter.
Seven Eight Capital sold 5,432 Cantel Medical Corporation shares in Q3 2020, an estimated $240K.
Seven Eight Capital first reported a position in Cantel Medical Corporation in Q2 2018 and held it in 2 quarters.
Seven Eight Capital's Cantel Medical Corporation position peaked at $452K in Q2 2018.
196 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2020.

Based on Seven Eight Capital's 13F filing for Q3 2020, filed 16 Nov 2020.